Craig R. Stapleton, Director at AVADEL PHARMACEUTICALS PLC (AVDL), bought 11,013 shares at $9.98 ($110K) on 2017-05-18, disclosed to the SEC on 2017-05-22.
Open-market purchase of $110k AVDL by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| AVDL | BUY | 2017-09-14 | $190K | — | Filing → |
| AVDL | BUY | 2017-05-22 | $305K | — | Filing → |
| FLML | BUY | 2016-11-30 | $216K | — | Filing → |